12:00 AM
 | 
Nov 04, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

BioTime management update

BioTime Inc. (NYSE-M:BTX), Alameda, Calif.
Business: Gene/Cell therapy, Pulmonary, Diagnostic
Transitioned: Jeffrey...

Read the full 38 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >